Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 15;60(1):163.
doi: 10.3390/medicina60010163.

CGRP Antagonism and Ketogenic Diet in the Treatment of Migraine

Affiliations
Review

CGRP Antagonism and Ketogenic Diet in the Treatment of Migraine

Francesca Finelli et al. Medicina (Kaunas). .

Abstract

The study of migraine is based on the complexity of the pathology, both at the pathophysiological and epidemiological levels. Although it affects more than a billion people worldwide, it is often underestimated and underreported by patients. Migraine must not be confused with a simple headache; it is a serious and disabling disease that causes considerable limitations in the daily life of afflicted people, including social, work, and emotional effects. Therefore, it causes a daily state of suffering and discomfort. It is important to point out that this pathology not only has a decisive impact on the quality of life of those who suffer from it but also on their families and, more generally, on society as a whole. The clinical picture of migraine is complex, with debilitating unilateral or bilateral head pain, and is often associated with characteristic symptoms such as nausea, vomiting, photophobia, and phonophobia. Hormonal, environmental, psychological, dietary, or other factors can trigger it. The present review focuses on the analysis of the physiopathological and pharmacological aspects of migraine, up to the correct dietary approach, with specific nutritional interventions aimed at modulating the symptoms. Based on the symptoms that the patient experiences, targeted and specific therapy is chosen to reduce the frequency and severity of migraine attacks. Specifically, the role of calcitonin gene-related peptide (CGRP) in the pathogenesis of migraine is analyzed, along with the drugs that effectively target the corresponding receptor. Particularly, CGRP receptor antagonists (gepants) are very effective drugs in the treatment of migraine, given their high diffusion in the brain. Moreover, following a ketogenic diet for only one or two months has been demonstrated to reduce migraine attacks. In this review, we highlight the diverse facets of migraine, from its physiopathological and pharmacological aspects to prevention and therapy.

Keywords: CGRP; gepants; headache; ketogenic diet; migraine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The CGRP receptor is a member of the B family of G-protein-coupled receptors (GPCR); calcitonin receptor-like receptor (CRL); receptor component protein (RCP); stimulatory G protein (Gs).

References

    1. Steiner T.J., Stovner L.J. Global epidemiology of migraine and its implications for public health and health policy. Nat. Rev. Neurol. 2023;19:109–117. doi: 10.1038/s41582-022-00763-1. - DOI - PubMed
    1. Tiwari R., Tiwari G., Mishra S., Ramachandran V. Preventive and therapeutic aspects of migraine for patient care: An insight. Curr. Mol. Pharmacol. 2023;16:147–160. doi: 10.2174/1874467215666220211100256. - DOI - PubMed
    1. Mangrum R., Gerstein M.T., Hall C.J., III, Buse D.C., Houts C.R., McGinley J.S., McCarrier K.P., Lipton R.B., Wirth R.J. Priority acute and preventive migraine treatment benefits: Results of the Migraine Clinical Outcome Assessment System (MiCOAS) qualitative study of people living with migraine. Headache. 2023. in press . - DOI - PMC - PubMed
    1. Silvestro M., Iannone L.F., Orologio I., Tessitore A., Tedeschi G., Geppetti P., Russo A. Migraine treatment: Towards new pharmacological targets. Int. J. Mol. Sci. 2023;24:12268. doi: 10.3390/ijms241512268. - DOI - PMC - PubMed
    1. Ursitti F., Valeriani M. Migraine in childhood: Gender differences. Eur. J. Paediatr. Neurol. 2023;42:122–125. doi: 10.1016/j.ejpn.2023.01.002. - DOI - PubMed

MeSH terms

Substances